Analysts say the adoption of GLP-1 drugs, the expansion of AI and the growth of multi-billion-dollar M&A deals chart an unpredictable path for the industry this year.

The Coors Light manufacturer’s 8.5% stake in the nonalcoholic carbonated mixer, worth $89 million, further builds on its long-term strategy of increasing its exposure beyond beer.

Wells Fargo analyst Christopher Carey maintained a Buy rating on Molson Coors (TAP – Research Report) yesterday and set a price target of ...

Molson Coors Beverage Company has announced a strategic partnership with Fever-Tree in the US, aiming to fuel its ...

Under President Donald Trump’s Project 2025, the administration has launched an unprecedented effort to dismantle diversity, ...

The majority owner of the new National Women's Soccer League team in Denver says there are plans to build a dedicated soccer stadium for the club.

The NWSL officially sealed the deal with Denver early Thursday, granting the league's 16th expansion team to the Mile High ...

By Shashwat Awasthi (Reuters) -Shares of Fevertree Drinks surged almost 24% after Molson Coors' took an 8.5% stake in the ...

The first professional women's sports team in a major national league will soon call Denver home as the National Women's ...

The deal gives Molson Coors exclusive commercialization rights to Fever-Tree’s U.S. portfolio, alongside an equity investment by Molson Coors into Fevertree Drinks plc Partnership designed to fuel ...

The Coors Light brewer will pay £71 million ($88 million) for 8.5% of Fevertree, a move that will help the Chicago-based company expand its non-alcoholic range.

(Alliance News) - Fevertree Drinks PLC on Thursday said it intends to launch a share buyback programme for up to GBP71.0 million, on the back of a new partnership with Molson Coors Beverage Co for the ...